Comment Period Closes for Medical Device Labels

Pharmaceutical & Medical Packaging News
January 1998 The comment period is over for FDA's draft guidance o­n medical device labeling. Intended for devices cleared through premarket approval (PMA) or premarket notification (510k) submissions, the new document will supersede the labeling requirements found in the blue-book memorandum #G91-1.

For full article Click Here